MassDevice Q&A

June 30, 2009 by MassDevice staff

Q&A Features

11/28/2012 by Brian Johnson

In this MassDevice Big 100 West preview we talk to Align Technology CEO Tom Prescott about how Invisalign crossed the chasm into mainstream culture through social media and aggressive consumer marketing strategies.

Align Technology CEO Tom Prescott

Crooked-toothed teens may want to consider sliding a picture of Tom Prescott next to that fading "Twilight" poster on the wall.

The CEO of Align Technology (NSDQ:ALGN) may...

11/13/2012 by Brad Perriello

Medical device company Sanovas is looking to raise about $25 million to commercialize its next-generation Vas Zeppelin pulmonary device designed to scan, diagnose and treat lung disease in a single sitting.

Sanovas CEO Larry Gerrans

Most startup medical device companies raise 10s of millions to research and develop their products before they even get to the commercial stage. But for Sanovas and co-founder Larry Gerrans, the 12-year journey to that point required a scant $9 million – all raised from the pulmonary device firm's founders, friends and family, Gerrans told last month.

"We've built the company with significant...

10/29/2012 by Brad Perriello

OmniGuide CEO Scott Flora tells about his plans to build commercial scale for its BeamPath surgical laser.

OmniGuide BeamPath first visited OmniGuide in 2009, when the Cambridge, Mass.-based medical device company was developing the BeamPath laser scalpel, aiming for 2 orders of magnitude more precision than the most precise soft-tissue cutting tool.

Today the company has refined that technology even further and has turned its focus toward ramping up commercialization of the BeamPath device, CEO Scott Flora told us this month.


10/17/2012 by Arezu Sarvestani

Medtech veteran Christopher Jones, the CEO of medical device company GlySure, tells about his experiences in the U.S. and across the pond, with some words of guidance for companies pursuing a Europe-1st strategy.

GlySure CEO Christopher Jones

GlySure CEO Christopher Jones has a career spanning more than 2 decades and 2 continents, during which he's seen the medtech regulatory pendulum swing from the Europe to the U.S. and back. 

In an exclusive interview with, Jones told us about being an American executive in the U.K., changing regulatory timelines and challenges to look for with a Europe-1st strategy.


08/27/2012 by Arezu Sarvestani

EnteroMedics CEO Mark Knudson and CFO Greg Lea tell about the company's Maestro weight loss pacemaker and how a twist on neuromodulation may help patients eat less and feel full without anatomy-altering surgery.

EnteroMedics VBLOC therapy

EnteroMedics (NSDQ:ETRM) is looking to control metabolic disease by attacking the problem closer to its source - human behavior.

"We tried to understand why people became over-weight and obese, and what was the underlying...

08/16/2012 by Arezu Sarvestani

The best way to beat Intuitive Surgical out of the corner it has on the prostate cancer treatment market is by amping up the aggression, radiosurgery veteran and Varian chief medical officer John Adler tells

boxing gloves

Radiosurgery innovator and medtech veteran John Adler is ready for a fight.

The outspoken inventor of Accuray's (NSDQ:ARAY) CyberKnife system, as well as the company's founder and former CEO, Adler is an evangelist for radiosurgery and its potential in a...

Syndicate content
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp